InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.00%
)
US TECH 100
18,164.00
(
0.75%
)
Dow Jones
38,686.32
(
0.00%
)
Brent Oil
80.40
(
-0.51%
)
Bitcoin
69,691.72
(
2.87%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Paulieme

Send PM Follow Ignore
Followers 3
Posts 607
Boards Moderated 0
Alias Born 06/07/2010

Paulieme

Re: None

Monday, 12/06/2010 11:49:38 AM

Monday, December 06, 2010 11:49:38 AM

Post# of 80490
Ariad (ARIA) May Have Been Best at ASH Meeting
December 6, 2010 9:02 AM EST
TheStreet.com's Adam Feurstein noted that buyside sources, commenting on the American Society of Hematology annual meeting, stated that:
Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) was the best story at the meeting. Seattle Genetics Inc. (Nasdaq: SGEN) was good but a small market, Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) data is tonight, Celgene Corporation (Nasdaq: CELG) comparable to Allos Therapeutics, Inc. (Nasdaq: ALTH).



http://www.streetinsider.com/FDA/Ariad+%28ARIA%29+May+Have+Been+Best+at+ASH+Meeting/6144734.html?si_email_click=2010120609
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up